HOME >> BIOLOGY >> NEWS
Virginia Tech researchers receive $450,000 award to model cell division

BLACKSBURG, Va., June 26, 2002 Cancer is a group of diseases involving misregulation of cell growth and division. The more we know about how cells grow and divide under normal circumstances, the better we will understand how things go awry in cancer cells.

For this reason, John Tyson, University Distinguished Professor of Biology at Virginia Tech, and Bela Novak, professor of biotechnology at the Budapest University of Technology and Economics, are developing mathematical models of the molecular mechanisms that control the way yeast cells grow and assume various shapes.

Their work is being supported by a $450,000 grant from the James S. McDonnell Foundation of St. Louis, Mo.

"Division and shape are important to yeasts because, by growing in specific directions, they are able to seek out viable environments and potential mates," Tyson said. "Understanding how yeast cells control these processes is important to us not only because of the cancer connection, but also because we are still very much in the dark about how genes regulate behavior in the broadest sense.

"While the genome project has provided a parts list of the cell, scientists need a schematic diagram of how all those parts hook together," Tyson said. "From the schematic diagram, we can write equations that govern the behavior of the control system, much like an electrical engineer can write equations for a circuit diagram. With these equations we can predict how a cell will behave under many different conditions."

Although a human cell is more evolved than a yeast cell, a human cell is made of the same sorts of parts that behave in the same way. It was found that "the molecular constituents of the cell cycle control system are functionally interchangeable between yeast and humans," Tyson said. "What we learn about cell division in yeast can be carried over to humans." From what they learn about the molecular mechanism of yeast cell growth and division, Tyson
'"/>

Contact: John Tyson
tyson@vt.edu
540-231-4662
Virginia Tech
26-Jun-2002


Page: 1 2

Related biology news :

1. Two Virginia Tech energy-related inventions win R&D 100 awards
2. Virginia Tech researchers to release findings on Smith River Project
3. Virginia Tech professor honored with DeLaval Award
4. Virginia Techs smelly corpse plant due to bloom Aug. 4
5. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
6. Virginia Center for Coal and Energy Research helps implement global climate change initiative
7. Cell cycle research earns biologist Virginias top scientist award
8. Virginia Tech-led group receives third five-year international biodiversity grant
9. Virginia Tech researcher receives $1.8 million to study Arabidopsis genome
10. Virginia Tech and North Carolina State University to run Forest Nutrition Research Cooperative
11. Virginia Bioinformatics Institute central to Regional Center of Excellence

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
(Date:1/19/2017)... CLARA, Calif. , Jan. 19, 2017 /PRNewswire/ ... company enhancing user experience and security for consumer ... of next-generation payment processing systems and cybersecurity solutions, ... more banks, enterprises and financial institutions worldwide to ... part of the end-to-end secure user authentication platforms ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... DNA (ctDNA) technologies, today announced that it has signed ... and the Middle East ...  This milestone marks the first wave of international distribution ... urine and blood samples. The initial partners ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... Feb. 17, 2017  If only one in ... a mutation-conferring resistance to chemotherapy, thousands of cancer ... has focused on finding these mutations in ever-smaller ... circulating tumor DNA in blood — to guide ... Unfortunately, however, detecting these genetic anomalies ...
(Date:2/16/2017)... MI (PRWEB) , ... February 16, 2017 , ... Avomeen ... p.m. The event will be held at Avomeen Analytical Services (4840 Venture Dr., ... a MichBio member organization. They provide an opportunity to interact with peers, make new ...
(Date:2/16/2017)... , Feb. 16, 2017  ArmaGen, Inc., ... groundbreaking therapies to treat severe neurological disorders, today ... treated with AGT-181, the company,s investigational therapy for ... known as mucopolysaccharidosis type I, or MPS I). ... proof-of-concept (POC) study, presented today at the 13 ...
(Date:2/16/2017)... 2017 Patient Care services ... telemedicine application, new and leading edge therapies and ... boom worldwide. The healthcare sector as whole continues ... and new therapies for companies such as Reliq ... Biosciences, Inc. (NASDAQ: CLRB ), Cytori ...
Breaking Biology Technology:
Cached News: